US Senior Medical Director, Rare Hematology

Sanofi•Cambridge, MA

3d•$206,250 - $343,750•Hybrid

About The Position

Join the team transforming care for people with immune challenges, rare diseases, cancers, and neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs. The US Senior Medical Director (SMD) is a Cambridge/Morristown-based member of the US Medical Affairs team within the Rare Blood Disorders franchise, covering the US geography. The mission of this team is to support the company by functioning as the internal expert in rare hematologic conditions — focusing on recent launch in Immune Thrombocytopenia (ITP), and potentially including warm Autoimmune Hemolytic Anemia (wAIHA), and Sickle Cell Disease (SCD) among other rare blood disorders — and helping Health Care Professionals and Payers optimize patient care and treatment outcomes through evidence-based decisions. This is best accomplished through the generation, interpretation, and communication of accurate clinical and scientific information. The Senior Medical Director plays a key role in this mission by providing strategic leadership across the rare hematology portfolio and reports to the Head of US Medical Affairs, Rare Blood Disorders. The Senior Medical Director has a national scope and is responsible for the rare hematology therapeutic area. The Senior Medical Director will establish and maintain collaborative medical and scientific relationships with key external physicians and internal constituencies from multiple functional groups — including, but not limited to, Medical Affairs, Clinical Research, Regulatory, Science, Marketing, Sales, Commercial Operations, and Patient and Product Services — while maintaining full compliance with all relevant company, industry, legal, and regulatory requirements. We are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases and blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.

Requirements

Doctorate degree (PhD, or PharmD). Will consider MD with relevant experience.
At least 10 years of Medical Affairs experience with strategic and tactical planning and execution
Experience in rare hematology or a related therapeutic area (ITP, wAIHA, SCD, or adjacent rare blood disorders)

Nice To Haves

Proven success as a strategic thinker and planner
Superb communication skills — oral and written, including presentation skills
Outstanding interpersonal skills, including building strong working relationships and managing and resolving conflict
Well-organized, with demonstrated ability to work effectively in a highly matrixed, cross-functional environment; strongly team-oriented
Experience in developing, conducting, and publishing peer-reviewed scientific or clinical research
Additional training or experience in epidemiology, health economics, or health policy and outcomes-based research and practice
Hard-working, energetic, and passionate about improving outcomes for patients with rare hematologic conditions
An unwavering commitment to upholding the highest ethical, legal, regulatory, and scientific standards

Responsibilities

Develop U.S. medical objectives and strategies across the rare hematology portfolio, aligned with U.S. commercial goals
Provide medical input to brand teams regarding strategy, tactics, and development of claims
Serve as the internal expert for rare hematologic conditions and products, and support the field-based U.S. Medical Affairs team
Develop strategies for and implement medical advisory boards
Lead execution of the strategic U.S. investigator-sponsored study program
Develop U.S. scientific communication and publication strategies
Partner with the R&D organization to support clinical trials across the rare hematology portfolio
Lead medical affairs activities in support of the near-term launch of rilzabrutinib (rilza) for ITP, serving as a key strategic and scientific resource during this critical launch phase
Engage and present to cross-functional leadership and governance forums to advance TA strategy
Drive preparation for future lifecycle management and upcoming product launches across the rare hematology portfolio, ensuring medical readiness and cross-functional alignment
Provide strategic direction to disease-specific MSL teams responsible for translating medical strategy into operational tactics
Support product and disease-state training of internal colleagues across the rare hematology portfolio
Support the Managed Markets group, particularly in discussions with payers regarding rare hematology therapies
Review Educational Outreach Grants to ensure alignment with strategic goals
Ensure ethical and credible promotion; potentially sit on Promotional and Medical Review boards
Ensure full compliance with all corporate and industry policies and legal and regulatory requirements for all Medical Affairs activities
Maintain medical and scientific knowledge through continuing education, including attending symposia and keeping abreast of current literature across rare hematologic conditions
Stay updated on emerging scientific, technological, and regulatory developments to inform strategic decision-making